in Newswire December 6, 2017

Teva Accused of Misleading Investors About Acquisition’s Success

by Erin Gilmore

Last Updated on December 6, 2017

Baker v. Teva Pharmaceutical Industries Ltd. et al.

Filed: August 30, 2017 § 2:17-cv-03902-GAM

Teva Pharmaceutical Industries Ltd. and three executives have been named as defendants in a proposed class action lawsuit that accuses them of violating federal securities laws by publishing false statements regarding their financial projections.

Last Updated on December 6, 2017 — 2:12 PM

Erin Gilmore

Erin works primarily on’s newswire, reporting on cases as they happen. She is an honest writer, a faithful friend, and a mediocre bassist.

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.